AU2003279308A1 - Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a) - Google Patents
Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a)Info
- Publication number
- AU2003279308A1 AU2003279308A1 AU2003279308A AU2003279308A AU2003279308A1 AU 2003279308 A1 AU2003279308 A1 AU 2003279308A1 AU 2003279308 A AU2003279308 A AU 2003279308A AU 2003279308 A AU2003279308 A AU 2003279308A AU 2003279308 A1 AU2003279308 A1 AU 2003279308A1
- Authority
- AU
- Australia
- Prior art keywords
- gpr73a
- therapeutics
- diagnostics
- diseases associated
- coupled receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02024570.0 | 2002-11-04 | ||
| EP02024570 | 2002-11-04 | ||
| PCT/EP2003/011685 WO2004042407A1 (en) | 2002-11-04 | 2003-10-22 | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003279308A1 true AU2003279308A1 (en) | 2004-06-07 |
Family
ID=32309307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003279308A Abandoned AU2003279308A1 (en) | 2002-11-04 | 2003-10-22 | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a) |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003279308A1 (en) |
| WO (1) | WO2004042407A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2439213B1 (en) | 2004-04-21 | 2018-12-12 | The Brigham and Women's Hospital, Inc. | Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding antibodies and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1147136A4 (en) * | 1998-12-10 | 2003-04-16 | Synaptic Pharma Corp | DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| EP1207198A4 (en) * | 1999-08-27 | 2004-03-03 | Takeda Chemical Industries Ltd | Novel g protein-coupled receptor protein and dna thereof |
| WO2001048188A1 (en) * | 1999-12-28 | 2001-07-05 | Helix Research Institute | Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same |
| US20020062013A1 (en) * | 1999-12-28 | 2002-05-23 | Peter Lind | Novel G protein-coupled receptors |
| CA2417195A1 (en) * | 2000-07-27 | 2002-02-07 | Incyte Genomics, Inc. | G-protein coupled receptors |
| EP1472376A4 (en) * | 2002-01-18 | 2007-03-21 | Millennium Pharm Inc | Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo |
-
2003
- 2003-10-22 WO PCT/EP2003/011685 patent/WO2004042407A1/en not_active Application Discontinuation
- 2003-10-22 AU AU2003279308A patent/AU2003279308A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004042407A1 (en) | 2004-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003214249A1 (en) | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) | |
| AU2003214072A1 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
| AU2003229735A1 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
| AU2003279308A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a) | |
| AU2003240589A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4) | |
| AU2003250128A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) | |
| AU2003273994A1 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
| AU2003240720A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5) | |
| AU2003229767A8 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
| AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| AU2003218638A1 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
| AU2003276106A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) | |
| AU2003250165A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19) | |
| AU2003206749A1 (en) | Diagnostics and therapeutics for diseases associated with the gpr65 receptor | |
| AU2003274005A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6) | |
| AU2003240721A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4) | |
| AU2003301892A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) | |
| AU2003229753A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
| AU2003283427A1 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) | |
| AU2003246726A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45) | |
| AU2003266238A1 (en) | Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) | |
| AU2003221502A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10) | |
| AU2003233333A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (ccr10) | |
| AU2003288250A1 (en) | Diagnostics and therapeutics for diseases associated with muscarinic acetylcholine receptor m1 (acm1) | |
| AU2003283266A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |